This study tests an experimental drug called TTX-MC138 in 16 adults with advanced solid tumors that have not responded to standard treatments. The goal is to check the drug's safety and see if it can shrink or stabilize tumors. Participants receive increasing doses to find the be…
Phase: PHASE1, PHASE2 • Sponsor: TransCode Therapeutics • Aim: Disease control
Last updated May 12, 2026 13:42 UTC